BioCardia, Inc. Accrued Liabilities, Current
BioCardia, Inc. (BCDA) had Accrued Liabilities, Current of $30.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $30.00K.
- 2026-03-31: Accrued Liabilities, Current $52.00K.
- 2025-12-31: Accrued Liabilities, Current $34.00K.
- 2025-09-30: Accrued Liabilities, Current $108.00K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $52.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $34.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $108.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $41.00K 10-Q/A · filed 2025-10-29 | |
| 2025-03-31 | $243.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $22.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $28.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $4.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $116.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $75.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $36.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $111.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $38.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $157.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $115.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $29.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $34.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $240.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $79.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $35.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $240.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $87.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $105.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $132.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $99.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $10.00K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $102.00K 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $739.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $596.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $127.00K 10-K · filed 2020-04-09 | $495.00K 10-K · filed 2019-04-02 |
| 2018-09-30 | $226.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $180.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $579.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $465.00K 10-K · filed 2019-04-02 | $539.00K 10-K · filed 2018-03-16 |
| 2017-09-30 | $487.00K 10-Q · filed 2017-11-09 | |
| 2017-03-31 | $720.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $478.00K 10-K · filed 2018-03-16 | $544.00K 10-K · filed 2017-03-30 |
| 2015-12-31 | $692.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |